Celularity- Warrants (16/07/2026) Profit Margin

The latest profit margin for CELUW is -246.73% as of June 2026. That compares with -195.47% in the prior-year period — down 26.2% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Celularity- Warrants (16/07/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CELUW's profit margin moved from -195.47% to -246.73% — a 26.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Celularity- Warrants (16/07/2026)'s valuation or profitability profile.

Against Healthcare companies, CELUW currently prints -246.73% for profit margin, while the sector average sits near 10.58%. That is roughly 2431.9% below the sector mean. Large gaps often invite a closer look at Celularity- Warrants (16/07/2026)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Celularity- Warrants (16/07/2026) converts resources into returns. At -246.73%, CELUW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -195.47% in the prior-year period — down 26.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CELUW's profit margin (-246.73%), review year-over-year change from -195.47%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.